Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Melina Herrera"'
Autor:
Sabrina Di Gregorio, Jesús Vielma, María Sol Haim, Lucía Rago, Josefina Campos, Mihir Kekre, Monica Abrudan, Àngela Famiglietti, Liliana Fernandez Canigia, Gabriela Rubinstein, Martha Helena von Specht, Melina Herrera, Carolina Aro, Marcelo Galas, Norah Balderrama Yarhui, Agnes Figueiredo, Nilton Lincopan, Miryan Falcon, Rosa Guillén, Teresa Camou, Gustavo Varela, David M. Aanensen, Silvia Argimón, Marta Mollerach
Staphylococcus aureusremains one of the leading causes of infections worldwide and a common cause of bacteremia. However, studies documenting the epidemiology ofS. aureusin South America (SA) using genomics are scarce. We hereby report on the largest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb1abbdf3241428c3753aebf102f3f5
https://doi.org/10.1101/2022.12.20.22283725
https://doi.org/10.1101/2022.12.20.22283725
Autor:
María Sol Haim, José Alejandro Di Conza, Graciela Posse, Marta Mollerach, Melina Herrera, Sabrina Di Gregorio
Publikováno v:
International Journal of Antimicrobial Agents. 57:106304
Tigecycline (TGC) resistance remains rare in Staphylococcus aureus worldwide. In this study, 12 TGC-resistant S. aureus mutants (TRSAm) were obtained displaying an increase in efflux activity. The isolates belonged to seven different genetic lineages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734b420a76e1a3358021e409db72276b
https://doi.org/10.1016/j.ijantimicag.2021.106304
https://doi.org/10.1016/j.ijantimicag.2021.106304
Autor:
Graciela Posse, Carlos Bantar, Viviana Ballerini, Melina Herrera, Liliana Mobilia, Adriana S. Limansky
Publikováno v:
Current Clinical Pharmacology. 8:332-339
Background: We present herein, a comparative study assessing the bactericidal kinetics of tigecycline, doxycycline, cefazolin and vancomycin against several methicllin-susceptible (MSSA) and –resistant (MRSA) Staphylococcus aureus isolates recovere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15259a3c8865cb3ca08264fc90ec0af2
https://doi.org/10.2174/15748847113089990063
https://doi.org/10.2174/15748847113089990063
Autor:
Marta Mollerach, Silvina Fernández, Melina Herrera, Graciela Posse, José Alejandro Di Conza, Sabrina Di Gregorio
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials
Background Tigecycline (TIG) is an antibiotic belonging to the glycylcyclines class and appears to be a good choice to fight infections caused by Staphylococcus aureus. To date, TIG exhibits good activity against this microorganism. The aim of this w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b616ef35da7c30cb4744aeb5c678a9
https://pubmed.ncbi.nlm.nih.gov/26956508
https://pubmed.ncbi.nlm.nih.gov/26956508